In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab’s (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD. He discusses the science behind the MedTech technology; the progress toward obtaining FDA approval; and, the real potential to develop screening for further neurological conditions. Professor Wang also highlights the strategic collaborations with other prestigious academic institutions.
More From The Market Online
ASX Market Close: October back again as DRO, EOS, 4DX pop; otherwise mid day
If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s
- Jonathon Davidson
- 3 mins
- 16 December 2025 15:06 (AEDT)
Inside Racura Oncology: Strategy, clinical milestones, and the year ahead
It's been a huge year for Racura Oncology, and CY26 only promises to get bigger as…
- Isaac McIntyre
- 1 min
- 17 December 2025 14:02 (AEDT)
How EVR’s 99% antimony concentrate sets up Los Lirios drilling
EVR chief executive Mike Brown joins The Market Link to talk all the latest developments unfolding…
- Isaac McIntyre
- 2 mins
- 17 December 2025 13:46 (AEDT)
Wednesday’s HotCopper trends: Boss, Treasury Wines, and other daily topics | Dec 17
With more than seven million users on the HotCopper forums, every discussion and speculation can move Australian markets, which is why getting out in front
- Isaac McIntyre
- 2 mins
- 17 December 2025 13:26 (AEDT)
